|
Volumn 22, Issue 1, 2012, Pages 472-475
|
Fused thiophene derivatives as MEK inhibitors
a
UCB PHARMA
(Belgium)
|
Author keywords
Allosteric MEK inhibitor; MEK; Non ATP competitive MEK inhibitor
|
Indexed keywords
2 (2 FLUORO 4 IODO PHENYLAMINO) 7,7 DIMETHYL 5,6,7,8 TETRAHYDRO THIAZOLO[5,4 C]AZEPIN 4 ONE;
2 METHYL PROPANE 1,2 DIAMINE;
ANTINEOPLASTIC AGENT;
HYDROXAMIC ACID;
MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;
PIPERIDINE 3 YLAMINE;
THIOPHENE DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CANCER INHIBITION;
CELL STRAIN HT29;
CHEMICAL REACTION;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG POTENCY;
DRUG SOLUBILITY;
DRUG SYNTHESIS;
FEMALE;
IN VIVO STUDY;
MOUSE;
NONHUMAN;
PHYSICAL CHEMISTRY;
SINGLE DRUG DOSE;
STRUCTURE ACTIVITY RELATION;
ANIMALS;
CELL LINE, TUMOR;
CHEMISTRY, PHARMACEUTICAL;
CRYSTALLOGRAPHY, X-RAY;
DRUG DESIGN;
DRUG SCREENING ASSAYS, ANTITUMOR;
HUMANS;
INHIBITORY CONCENTRATION 50;
MAP KINASE KINASE KINASES;
MICE;
MODELS, CHEMICAL;
PHOSPHORYLATION;
PROTEIN KINASE INHIBITORS;
STATIC ELECTRICITY;
STRUCTURE-ACTIVITY RELATIONSHIP;
THIOPHENES;
TIME FACTORS;
|
EID: 84655164863
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2011.10.105 Document Type: Article |
Times cited : (17)
|
References (17)
|